MARIE SERFIS: Open Payments
NPI 1457130601 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 92 payments from 22 companies in 2025. Trend: 2023 $21 · 2024 $889 · 2025 $1,388
Food & beverage: $1,369Education: $19
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $351 |
| ABBVIE INC. | 28 | $258 |
| Novo Nordisk Inc | 11 | $212 |
| Lilly USA, LLC | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 4 | $53 |
| Amgen Inc. | 3 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Abbott Laboratories | 2 | $34 |
Products named: NURTEC ODT, PREVNAR 20, QULIPTA, UBRELVY, Ozempic, MOUNJARO, Wegovy, XIFAXAN.
Industry payments across VA — which companies pay providers there.
